NASDAQ: HSTM
Healthstream Inc Stock

$26.11+0.45 (+1.75%)
Updated Jun 24, 2026
HSTM Price
$26.11
Fair Value Price
$75.98
Market Cap
$762.81M
52 Week Low
$19.50
52 Week High
$29.63
P/E
38.97x
P/B
2.17x
P/S
1.95x
PEG
3.17x
Dividend Yield
0.51%
Revenue
$311.78M
Earnings
$19.92M
Gross Margin
64.9%
Operating Margin
8.27%
Profit Margin
6.4%
Debt to Equity
0.5
Operating Cash Flow
$63M
Beta
0.54
Next Earnings
Aug 3, 2026
Ex-Dividend
N/A
Next Dividend
N/A

HSTM Overview

HealthStream, Inc., established in 1990 and headquartered in Nashville, Tennessee, delivers specialized workforce and provider solutions to healthcare organizations throughout the United States. Its operations are divided into two primary segments: Workforce Solutions and Provider Solutions. The Workforce Solutions segment provides a suite of software-as-a-service (SaaS) and subscription-based tools. These comprehensive services address various aspects of healthcare staff development and management, encompassing clinical skill enhancement, talent acquisition and retention, training programs, educational resources, professional certification, scheduling logistics, competency evaluations, and performance reviews. Additionally, this segment offers support through implementation and account management. Specific applications under this umbrella cover learning platforms, performance assessment, competency tracking, disclosure management, clinical skill evaluation, simulation-based learning, quality assurance, and sector-specific training. Complementing this, the Provider Solutions segment focuses on administrative and operational needs. It includes VerityStream, an enterprise platform designed to optimize the experience for healthcare providers across diverse settings such as ambulatory surgery centers, urgent care clinics, medical groups, and other facilities. Furthermore, HealthStream offers EchoCredentialing and MSOW platforms to streamline the credentialing, enrollment, and privileging processes for medical staff in hospitals. EchoOneApp facilitates provider enrollment for medical groups. Other key offerings comprise CredentialMyDoc, a SaaS solution for credentialing and enrollment for medical groups and surgery centers; CredentialStream, another SaaS-based platform for provider credentialing, privileging, and enrollment; and NurseGrid Mobile, a dedicated application for nurse managers. These diverse solutions are marketed directly to a broad spectrum of healthcare entities, including private, non-profit, and governmental organizations, as well as pharmaceutical and medical device manufacturers.

Zen Rating

Our proven quant model uses 115 proprietary factors, including AI, to determine HSTM's potential to beat the market

BBuy
  • Stocks with a Zen Rating of Buy (B) had an average return of +19.88% per year. Learn More

Zen Rating Component Grades

C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.

Industry: Health Information Service

Industry Rating
C
HSTM
Ranked
#7 of 43

Top Ranked Stocks in Industry

Name / TickerPriceZen Rating
$39.49A
$67.61A
$26.89A
View Top Health Information Service Stocks

Be the first to know about important HSTM news, forecast changes, insider trades & much more!

HSTM News

Overview

Due Diligence Score

Industry Average (30)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how HSTM scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

HSTM ($26.11) is undervalued by 65.63% relative to our estimate of its Fair Value price of $75.98 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
HSTM ($26.11) is significantly undervalued by 65.63% relative to our estimate of its Fair Value price of $75.98 based on Discounted Cash Flow (DCF) modelling, which includes a healthy margin of safety
Significantly Below Fair Value Valuation
HSTM ($26.11) is trading above... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 35 more HSTM due diligence checks available for Premium users.

Valuation

HSTM fair value

Fair Value of HSTM stock based on Discounted Cash Flow (DCF)

Price
$26.11
Fair Value
$75.98
Undervalued by
65.63%
HSTM ($26.11) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
HSTM ($26.11) is significantly undervalued... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
HSTM ($26.11) is trading above... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

HSTM price to earnings (PE)

For valuing profitable companies with steady earnings

Company
38.97x
Industry
13.56x
Market
7.39x
HSTM is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
HSTM is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation

HSTM price to book (PB)

For valuing companies that are loss-making or have lots of physical asset

Company
2.17x
Industry
3.14x
HSTM is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

HSTM price to earnings growth (PEG)

For valuing profitable companies with growth potential

HSTM is poor value relative... subscribe to Premium to read more.
PEG Value Valuation

HSTM's financial health

Profit margin

Revenue
$81.2M
Net Income
$5.9M
Profit Margin
7.3%
HSTM's Earnings (EBIT) of $25.79M... subscribe to Premium to read more.
Interest Coverage Financials
HSTM's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$527.4M
Liabilities
$175.4M
Debt to equity
0.5
HSTM's short-term liabilities ($136.51M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
HSTM's short-term assets ($133.02M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
HSTM's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
HSTM's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
$27.1M
Investing
-$6.3M
Financing
-$8.3M
HSTM's operating cash flow ($63.38M)... subscribe to Premium to read more.
Debt Coverage Financials

HSTM vs Health Information Service Stocks

TickerZen RatingMarket Cap1d %P/EP/B
HSTMB$762.81M+1.75%38.97x2.17x
CERTC$844.72M+0.56%-54.30x0.83x
TALK$869.39M-0.19%519.00x7.69x
PHRB$592.78M+4.81%63.93x1.65x
GDRXC$934.74M+3.37%46.00x1.50x

Healthstream Stock FAQ

What is Healthstream's quote symbol?

(NASDAQ: HSTM) Healthstream trades on the NASDAQ under the ticker symbol HSTM. Healthstream stock quotes can also be displayed as NASDAQ: HSTM.

If you're new to stock investing, here's how to buy Healthstream stock.

What is the 52 week high and low for Healthstream (NASDAQ: HSTM)?

(NASDAQ: HSTM) Healthstream's 52-week high was $29.63, and its 52-week low was $19.50. It is currently -11.86% from its 52-week high and 33.9% from its 52-week low.

How much is Healthstream stock worth today?

(NASDAQ: HSTM) Healthstream currently has 29,215,188 outstanding shares. With Healthstream stock trading at $26.11 per share, the total value of Healthstream stock (market capitalization) is $762.81M.

Healthstream stock was originally listed at a price of $8.50 in Apr 11, 2000. If you had invested in Healthstream stock at $8.50, your return over the last 26 years would have been 207.18%, for an annualized return of 4.41% (not including any dividends or dividend reinvestments).

How much is Healthstream's stock price per share?

(NASDAQ: HSTM) Healthstream stock price per share is $26.11 today (as of Jun 24, 2026).

What is Healthstream's Market Cap?

(NASDAQ: HSTM) Healthstream's market cap is $762.81M, as of Jun 26, 2026.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Healthstream's market cap is calculated by multiplying HSTM's current stock price of $26.11 by HSTM's total outstanding shares of 29,215,188.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.